Life Sciences Projections & Priorities for 2025/26
Top-line growth is expected primarily through volume increases of established products and brands, as well as acquisitions. Mergers & Acquisitions (M&A) are seen as the preferred growth strategy, while geographical expansion is less relevant due to geopolitical risks. The study highlights the importance of AI innovations, cost control, and global regulatory harmonization.